No association was found between FGF21 levels and the risk of CV death among patients with CAD after the effect size synthesis with substantial heterogeneity (RR: 1.04, 95% CI: 0.93–1.17, P > 0.05, I2 = 80%, random-effect model; Figure 3C). The gene discussed is FGF21; the disease is coronary artery disorder.